ストックスクリーナーアプリを入手
0.00
100.00%
-6.75
前日終値:
$6.75
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$26.62M
収益：
-
当期純損益:
$-117.67M
株価収益率:
0.00
EPS:
-3.09
ネットキャッシュフロー:
$-101.06M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$8.36
Athira Pharma Inc Stock (ATHA) Company Profile
名前
Athira Pharma Inc
セクター
電話
(425) 620-8501
住所
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
ATHA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.00 | 26.62M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.61 | 119.76B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
759.18 | 79.35B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
851.72 | 51.71B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
351.80 | 44.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.38 | 38.18B | 4.98B | 69.60M | 525.67M | 0.5198 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-19 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-09-04 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-09-04 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | 開始されました | Rodman & Renshaw | Buy |
| 2022-10-17 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-06-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-23 | ダウングレード | Stifel | Buy → Hold |
| 2022-05-10 | 開始されました | BTIG Research | Buy |
| 2022-04-21 | 開始されました | Berenberg | Buy |
| 2021-12-15 | 開始されました | Goldman | Neutral |
| 2020-10-13 | 開始されました | Goldman | Buy |
| 2020-10-13 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-13 | 開始されました | Jefferies | Buy |
| 2020-10-13 | 開始されました | Stifel | Buy |
すべてを表示
Athira Pharma Inc (ATHA) 最新ニュース
VIX Spike: Can Athira Pharma Inc ride the EV wave2025 Market Sentiment & Technical Pattern Based Signals - baoquankhu1.vn
Gainers Report: Can Athira Pharma Inc ride the EV wavePortfolio Risk Report & Verified Trade Idea Suggestions - baoquankhu1.vn
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer - marketscreener.com
Market Leaders: Can Athira Pharma Inc ride the EV waveWeekly Trade Report & Intraday High Probability Setup Alerts - baoquankhu1.vn
What’s the beta of Athira Pharma Inc. stockQuarterly Market Summary & Proven Capital Preservation Tips - Mfd.ru
Athira Pharma shares surge after securing rights to phase 3 breast cancer therapy - MSN
Aug Shorts: How correlated is Ralph Lauren Corporation to the S P500Earnings Recap Report & Growth-Oriented Investment Plans - baoquankhu1.vn
Published on: 2026-01-22 23:48:31 - baoquankhu1.vn
EV Market: Can Athira Pharma Inc maintain its current growth rateJuly 2025 Movers & Growth Focused Stock Reports - baoquankhu1.vn
Leonabio Inc files for offering of up to 58.5 million shares of common stock by the selling stockholders - marketscreener.com
Signal Recap: Will Athira Pharma Inc outperform during market ralliesJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - baoquankhu1.vn
Smart Money: Is Athira Pharma Inc a play on infrastructure spendingBreakout Watch & Verified Momentum Watchlists - baoquankhu1.vn
Aug Sectors: Is Macys Inc a potential multi bagger2025 Dividend Review & High Win Rate Trade Tips - baoquankhu1.vn
Aug Macro: What is the long term forecast for Athira Pharma Inc stockMarket Growth Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Patterns Watch: Whats the beta of Athira Pharma Inc stockBear Alert & Short-Term Swing Trade Alerts - baoquankhu1.vn
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker "LONA" - Investing News Network
Athira Pharma, Inc. (NASDAQ:ATHA) Sees Significant Growth in Short Interest - Defense World
Athira Pharma (ATHA) Options to Be Delisted on January 12th - GuruFocus
Why retail investors favor Athira Pharma Inc. stockPortfolio Profit Report & Fast Entry and Exit Trade Plans - Улправда
Athira Pharma Reports Reduced Losses Amid Cost Cuts - MSN
LONA Stock Price, News & Analysis - Stock Titan
Athira Pharma Rebrands as LeonaBio, Refocusing on Oncology - TipRanks
Athira Pharma announces name change to LeonaBio - TipRanks
Athira Pharma changes name, ticker symbol - MSN
Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy - Investing.com Nigeria
Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy By Investing.com - Investing.com South Africa
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker 'LONA” - The Manila Times
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA” - Chartmill
Trade Report: How strong is Athira Pharma Inc. stock balance sheetGDP Growth & Expert Verified Stock Movement Alerts - moha.gov.vn
Bull Run: Can Athira Pharma Inc. stock sustain revenue growthTrend Reversal & Free High Accuracy Swing Entry Alerts - Улправда
How analysts rate Athira Pharma Inc. stock todayWatch List & Stepwise Swing Trade Plans - ulpravda.ru
Will Athira Pharma Inc. stock continue upward momentumJuly 2025 Volume & Weekly Watchlist for Hot Stocks - Улправда
Can Athira Pharma Inc. stock sustain revenue growthQuarterly Profit Summary & Low Risk Entry Point Guides - ulpravda.ru
How sustainable is Athira Pharma Inc. stock dividend payoutMarket Sentiment Report & Community Consensus Picks - ulpravda.ru
Athira Pharma, Inc.Common Stock (NQ: ATHA - FinancialContent
Quarterly Trades: How sustainable is Athira Pharma Inc. stock dividend payoutJuly 2025 PreEarnings & Accurate Buy Signal Notifications - Улправда
Athira Pharma (NASDAQ:ATHA) CEO Mark James Litton Sells 2,586 Shares - Defense World
Athira Pharma CSO Church sells $6k in ATHA stock By Investing.com - Investing.com Canada
Athira Pharma CSO Church sells $6k in ATHA stock - Investing.com
Aug Analyst Calls: How 1CM Inc IQ70 stock performs during market turbulence2025 Retail Activity & Short-Term Trading Opportunity Alerts - moha.gov.vn
Immix Biopharma (NASDAQ:IMMX) & Athira Pharma (NASDAQ:ATHA) Critical Survey - Defense World
EDGAR Filing Documents for 0001193125-25-323692 - SEC.gov
Athira Pharma Stock Rockets 92% With 5-Day Winning Streak - Trefis
Athira Pharma Licenses Lasofoxifene For Metastatic Breast Cancer, Secures $236 Million Funding - Voice Of HealthCare
Athira Pharma recovers from Alzheimer’s failure with breast cancer pivot and $90M investment - MSN
How strong is Athira Pharma Inc. stock balance sheetMarket Sentiment Report & Weekly High Return Stock Opportunities - bolumsonucanavari.com
Can Athira Pharma Inc. stock beat analyst upgradesTrade Signal Summary & Precise Buy Zone Identification - Улправда
Does Athira Pharma Inc. stock trade at a discount to peersJuly 2025 Big Picture & Daily Volume Surge Signals - Улправда
Volume Summary: Why retail investors favor Athira Pharma Inc. stockJuly 2025 Technicals & AI Powered Market Entry Ideas - Улправда
Athira Pharma Inc. (ATHA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mizuho maintains Neutral on Athira Pharma stock after transformative deals By Investing.com - Investing.com Canada
Athira Pharma Inc (ATHA) 財務データ
収益
当期純利益
現金流量
EPS
1.22%
2.07%
大文字化:
|
ボリューム (24 時間):